Informations:
Erreur:
ID
12213
Description
Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02143622
Lien
https://clinicaltrials.gov/show/NCT02143622
Mots-clés
Versions (1)
- 18/10/2015 18/10/2015 -
Téléchargé le
18 octobre 2015
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Head and Neck Squamous Cell Carcinoma NCT02143622
Eligibility Head and Neck Squamous Cell Carcinoma NCT02143622
- StudyEvent: Eligibility
Similar models
Eligibility Head and Neck Squamous Cell Carcinoma NCT02143622
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
cetuximab; platinum
Item
most recent regimen contains both platinum and cetuximab (phase ii, group b).
boolean
C0995188 (UMLS CUI [1])
C0032207 (UMLS CUI [2])
C0032207 (UMLS CUI [2])
ecog performance status
Item
ecog performance status (ps) ≤ 2.
boolean
C1520224 (UMLS CUI [1])
Antineoplastic Drug/Agent Therapy
Item
recovery from all aes of previous anti-cancer therapies, to baseline or to ctcae grade ≤ 1, except for alopecia.
boolean
C2346834 (UMLS CUI [1])
measurable disease
Item
measurable disease as determined by recist v1.1.
boolean
C1513041 (UMLS CUI [1])
treatment specific antibody
Item
previous anti-her3 antibody treatment.
boolean
C0087111 (UMLS CUI [1,1])
C0443640 (UMLS CUI [1,2])
C0443640 (UMLS CUI [1,2])
symptomatic; metastasis; brain
Item
symptomatic brain metastasis.
boolean
C0231220 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
C0006104 (UMLS CUI [3])
C0027627 (UMLS CUI [2])
C0006104 (UMLS CUI [3])
cancer treatment; systemic
Item
prior systemic anti-cancer treatment, within a period of time that is shorter than the cycle length used for that treatment prior to starting study treatment.
boolean
C0920425 (UMLS CUI [1])
C0205373 (UMLS CUI [2])
C0205373 (UMLS CUI [2])
allergy human immunoglobulin
Item
prior anaphylactic or other severe infusion reaction to human immunoglobulin or antibody formulations.
boolean
C0020517 (UMLS CUI [1,1])
C3537193 (UMLS CUI [1,2])
C3537193 (UMLS CUI [1,2])
Organ or Tissue Function
Item
inadequate end organ function.
boolean
C1254358 (UMLS CUI [1])
diarrhea
Item
ongoing diarrhea ctcae grade ≥ 2. other protocol-defined inclusion/exclusion criteria may apply
boolean
C0011991 (UMLS CUI [1])